Japanese version of rPATD validated to assess attitudes toward medication reductions among patients, caregivers

Polypharmacy—the concurrent use of multiple medications—is a global challenge, and the active participation of patients and their families in decisions about medication use is essential. In a new study, researchers at University of Tsukuba, Hokkaido University of Science, and Keio University developed and validated a Japanese version of the revised Patients' Attitudes Towards Deprescribing (rPATD). It is an internationally recognized questionnaire designed to assess attitudes toward medication reductions among patients and their caregivers.